The Cancer Institute Administrative Office (AO) plays a crucial role in providing resources and efficient and effective administrative expertise to support the complex and expanding cancer basic and clinical research enterprise across the NYU Langone Medical Center. This includes administrative support to the Office of the Director, Associate Directors, Shared Resource Directors, Program Leaders, and NYUCI membership, as well as the investigators at the Cancer Research Center and the faculty in the Division of Hematology and Medical Oncology. The overarching goal for administration is to facilitate research and provide the infrastructure to move discoveries into the clinical setting. This is done through strategic planning and evaluation initiatives, business and financial planning for research programs and shared resources, development of policies and procedures for prudent financial and grants management for investigators at the Cancer Research Center and Division of Hematology and Medical Oncology, staffing of program meetings, scientific retreats, and seminars, supporting the submission of administratively demanding complex grants such as SPORE's and training grants, human resources, budget and finance, space, informatics, and facilities planning. The administrative team is responsible for all interactions across the NYU Langone Medical Center corporate offices (Grants Finance, Finance, IRB, Office of Clinical Trials, Office of Collaborative Sciences, Sponsored Programs Administration, Medical Center IT, and the Office of Communications). The AO provides services beyond the activities related to the CCSG such as fiscal management of clinical activities, auditing and oversight of clinical research billing compliance, the integration of clinical research operations throughout all clinical sites at the Cancer Institute, and academic and administrative oversight of the Division of Hematology and Medical Oncology and the Cancer Research Laboratories. The core mission of the CCSG defines and dictates the structure and decision-making processes within the administrative unit. There are eight major areas of focus for research administration: central CCSG administration, grants management, membership, shared resources, structure for inter- and intra-disciplinary collaborations, research program support, informatics, and financial management of the Cancer Institute. Support is requested for only those activities directly related to the CCSG.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
New York
United States
Zip Code
Jin, Honglei; Yu, Yonghui; Hu, Young et al. (2015) Divergent behaviors and underlying mechanisms of cell migration and invasion in non-metastatic T24 and its metastatic derivative T24T bladder cancer cell lines. Oncotarget 6:522-36
Zhou, Sherry; Weitzman, Michael; Vilcassim, Ruzmyn et al. (2015) Air quality in New York City hookah bars. Tob Control 24:e193-8
Brocato, Jason; Costa, Max (2015) 10th NTES Conference: Nickel and arsenic compounds alter the epigenome of peripheral blood mononuclear cells. J Trace Elem Med Biol 31:209-13
Cohen, Mitchell D; Vaughan, Joshua M; Garrett, Brittany et al. (2015) Acute high-level exposure to WTC particles alters expression of genes associated with oxidative stress and immune function in the lung. J Immunotoxicol 12:140-53
Ota, Mitsuhiko; Horiguchi, Masahito; Fang, Victoria et al. (2014) Genetic suppression of inflammation blocks the tumor-promoting effects of TGF-? in gastric tissue. Cancer Res 74:2642-51
McKinney, Caleb; Zavadil, Jiri; Bianco, Christopher et al. (2014) Global reprogramming of the cellular translational landscape facilitates cytomegalovirus replication. Cell Rep 6:9-17
Vazquez-Cintron, Edwin J; Vakulenko, Maksim; Band, Philip A et al. (2014) Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm. PLoS One 9:e85517
Jhaveri, Komal; Chandarlapaty, Sarat; Lake, Diana et al. (2014) A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. Clin Breast Cancer 14:154-60
Wu, Meng; Yang, Feikun; Ren, Zhihua et al. (2014) Identification of the nuclear localization signal of SALL4B, a stem cell transcription factor. Cell Cycle 13:1456-62
Kaneko, Syuzo; Bonasio, Roberto; SaldaƱa-Meyer, Ricardo et al. (2014) Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol Cell 53:290-300

Showing the most recent 10 out of 491 publications